Samyang Holdings Corporation

Samyang Biopharmaceuticals Corporation

Hye Jung Lim

Sang Yeob Park

Min Hyo Seo

Sa Won Lee

Jae Young Lee

Disclosed are an oral solid dosage form composition comprising an active ingredient and a solubilizing carrier wherein a foaming ingredient is used to improve disintegration, dispersion or dissolution, and a preparation method therefor.

Oral solid dosage form composition having improved disintegration and preparation method therefor

The present disclosure relates to an oral tablet composition comprising lenalidomide and a method for preparing the same. More particularly, the present disclosure relates to a tablet-type composition and a method for preparing the same wherein the composition exhibits physicochemical equivalence with lenalidomide preparations of hard capsules, has the same pharmacological, therapeutic effect in non-clinical studies and bioequivalence studies, and also has improved ease of taking, handling, safety and the like.

Oral tablet formulation of lenalidomide

Disclosed are an oral formulation which disintegrates quickly in the oral cavity; a fast-disintegrating tablet having fast disintegrability and high hardness, and a process for manufacturing the same. In addition, slightly wetted granules for manufacturing said fast-disintegrating tablet and a process for manufacturing the same are disclosed.

Growing community of inventors

Daejeon, South Korea

Hye Jung Lim